Bank of America’s Ginkgo Bioworks DNA Stock Holding History

Bank of America’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,000	Closed	-$78.8K	–	8387
2025 Q2	$78.8K	Sell	7,000 -33,700	-83%	-$261K	﹤0.01%	6629
2025 Q1	$232K	Buy	+40,700	New	+$415K	﹤0.01%	6089
2023 Q1	–	Sell	-298	Closed	-$20.1K	–	7896
2022 Q4	$20.1K	Sell	298 -10,000	-97%	-$920K	﹤0.01%	6735
2022 Q3	$1.28M	Buy	10,298 +10,000	+3,356%	+$1.19M	﹤0.01%	4679
2022 Q2	$28K	Sell	298 -30,000	-99%	-$3.66M	﹤0.01%	7067
2022 Q1	$4.88M	Buy	30,298 +14,835	+96%	+$2.89M	﹤0.01%	3660
2021 Q4	$5.14M	Buy	+15,463	New	+$7.35M	﹤0.01%	3621

Other funds holding DNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America's DNA Position: Q1 2026 in Review

Bank of America reduced its Ginkgo Bioworks (DNA) stake by 21% in Q1 2026, selling an estimated $1.05M and leaving 476,913 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #3850.

Bank of America first reported a position in DNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $37M in Q4 2024. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

Bank of America held 476,913 shares of Ginkgo Bioworks worth $2.92M as of Q1 2026.
Bank of America sold 125,663 Ginkgo Bioworks shares in Q1 2026, an estimated $1.05M.
Ginkgo Bioworks made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3850 holding.
Bank of America first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 19 quarters since.
Bank of America's Ginkgo Bioworks position peaked at $37M in Q4 2024.
174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.